Options
Hypoxic pulmonary hypertension in chronic lung diseases: novel vasoconstrictor pathway
Date Issued
2016-03
Date Available
2016-08-16T01:00:10Z
Abstract
Pulmonary hypertension is a well recognised complication of chronic hypoxic lung diseases, which are among the most common causes of death and disability worldwide. Development of pulmonary hypertension independently predicts reduced life expectancy. In chronic obstructive pulmonary disease, long-term oxygen therapy ameliorates pulmonary hypertension and greatly improves survival, although the correction of alveolar hypoxia and pulmonary hypertension is only partial. Advances in understanding of the regulation of vascular smooth muscle tone show that chronic vasoconstriction plays a more important part in the pathogenesis of hypoxic pulmonary hypertension than previously thought, and that structural vascular changes contribute less. Trials of existing vasodilators show that pulmonary hypertension can be ameliorated and systemic oxygen delivery improved in carefully selected patients, although systemic hypotensive effects limit the doses used. Vasoconstrictor pathways that are selective for the pulmonary circulation can be blocked to reduce hypoxic pulmonary hypertension without causing systemic hypotension, and thus provide potential targets for novel therapeutic strategies.
Sponsorship
Health Research Board
Science Foundation Ireland
Type of Material
Journal Article
Publisher
Elsevier
Journal
The Lancet Respiratory Medicine
Volume
4
Issue
3
Start Page
225
End Page
236
Copyright (Published Version)
2016 Elsevier
Language
English
Status of Item
Peer reviewed
This item is made available under a Creative Commons License
File(s)
No Thumbnail Available
Name
Rowan_et_al_THELANCETRM-D-15-00436_RMS_Upload.pdf
Size
679.12 KB
Format
Owning collection
Scopus© citations
61
Acquisition Date
Mar 28, 2024
Mar 28, 2024
Views
1810
Last Month
1
1
Acquisition Date
Mar 28, 2024
Mar 28, 2024
Downloads
1141
Last Week
8
8
Last Month
40
40
Acquisition Date
Mar 28, 2024
Mar 28, 2024